China's Best One-Stop Medical Equipment Provider
About

Pregnolia AG is a Swiss medtech company focused on women's health, particularly in improving pregnancy care. Founded in 2016 as a spin-off from ETH Zurich, the company specializes in developing diagnostic devices that predict the risk of premature birth by measuring cervical stiffness. This proprietary technology is CE-marked and designed for point-of-care use, allowing healthcare providers to obtain quick and reliable measurements during routine pregnancy consultations. The team at Pregnolia combines scientific, technical, and medical expertise, led by CEO Dr. Sabrina Badir and VP of R&D Dr. Francisco Delgado. The company is compliant with EN ISO 13485:2021 quality management standards and has raised approximately CHF 6.6 million to support product development and market expansion, including entry into the US market. Pregnolia's mission is to enhance pregnancy care through innovative diagnostics, ultimately aiming to reduce the incidence and consequences of premature births.

Technologies
GmailGoogle AppsGoogle Cloud HostingGoogle Dynamic RemarketingDoubleClick ConversionGoogle Tag ManagerWixVarnishDoubleClickGoogle AnalyticsMobile FriendlyRemoteAI
Keywords
medical devicesmedical equipment manufacturingbiotechnologyclinical studiescervical stiffness measurementobstetricsgynecologybiomechanical assessmentmedical device innovationmedical equipment and supplies manufacturingpreterm birth risk assessmentmedical deviceb2be-commercerisk predictionsingle-use probebiomechanics during pregnancyeth researchresearch and developmentprenatal diagnosticsearly detection of preterm laborpregnancy carece certifiedhealthcarecontrol unitobjective cervical assessmentservicesmanufacturingdistributionhospital & health care
Company Information
  • Employees8
  • Founded2016
  • Annual Revenue$3862000
  • Total Funding$7739850
Location

33 Wiesenstrasse, Schlieren, Zurich, Switzerland, 8952

Related Companies
Companies in the same industry